stock jumped early Wednesday after the drugmaker reported adjusted earnings of $1.20 per share on $10.06 billion in first-quarter sales, based on today's exchange rates.
Analysts surveyed by FactSet, on average, projected GSK earnings of $1.06 per share on $9.72 billion in sales.
↑ X How…